Després PC, Shapiro RS, Cuomo CA. New approaches to tackle a rising problem: Large-scale methods to study antifungal resistance. PLoS pathogens. 2024;20(9):e1012478. doi:10.1371/journal.ppat.1012478
Publications
Sundaram L, Kumar A, Zatzman M, et al. Single-cell chromatin accessibility reveals malignant regulatory programs in primary human cancers. Science (New York, N.Y.). 2024;385(6713):eadk9217. doi:10.1126/science.adk9217
Penter L, Cieri N, Maurer K, et al. Tracking rare single donor and recipient immune and leukemia cells after allogeneic hematopoietic cell transplantation using mitochondrial DNA mutations. Blood cancer discovery. 2024. doi:10.1158/2643-3230.BCD-23-0138
Zheng XF, Sarkar A, Lotana H, et al. CDK5-cyclin B1 regulates mitotic fidelity. Nature. 2024. doi:10.1038/s41586-024-07888-x
Wang X, Zhao J, Marostica E, et al. A pathology foundation model for cancer diagnosis and prognosis prediction. Nature. 2024. doi:10.1038/s41586-024-07894-z
Liu I, Cruzeiro GAV, Bjerke L, et al. GABAergic neuronal lineage development determines clinically actionable targets in diffuse hemispheric glioma, H3G34-mutant. Cancer cell. 2024. doi:10.1016/j.ccell.2024.08.006
Zheng XF, Sarkar A, Lotana H, et al. CDK5-cyclin B1 regulates mitotic fidelity. Nature. 2024. doi:10.1038/s41586-024-07888-x
Wang X, Zhao J, Marostica E, et al. A pathology foundation model for cancer diagnosis and prognosis prediction. Nature. 2024. doi:10.1038/s41586-024-07894-z
Liu I, Cruzeiro GAV, Bjerke L, et al. GABAergic neuronal lineage development determines clinically actionable targets in diffuse hemispheric glioma, H3G34-mutant. Cancer cell. 2024. doi:10.1016/j.ccell.2024.08.006
Vinceti A, Iannuzzi RM, Boyle I, et al. Author Correction: A benchmark of computational methods for correcting biases of established and unknown origin in CRISPR-Cas9 screening data. Genome biology. 2024;25(1):239. doi:10.1186/s13059-024-03387-4